The article is very well written and makes good points.
Note at the end this comment:
Dr Roberts’ appointment adds vital independence to Oncosil’s board. The company lost several experienced directors last financial year and since then has failed to follow the ASX Corporate Governance Council’s recommendation that a majority of a company’s board comprise independent directors.
That is a huge failure in leadership / Chairmanship or whatever you want to call it. No real excuses for not having a follow up appointment even interim, as it does raise serious questions of why they didnt appoint a replacement at a time of major decision making and change. Actually - I dont think it does raise questions, it it is just that they may not want to hear what we think are the answers.
OSL Price at posting:
24.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)